Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.

Main Inclusion Criteria:

• Good general health
• Phototype I to IV
• Mild to moderate SCORAD (between 15 and 25)

Main Exclusion Criteria:

• Pregnant/breastfeeding female or who have planned a pregnancy during the study period
• Positive history for atopy or hypersensitive skin
• Subjects under systemically pharmacological treatment
• Subjects under locally pharmacological treatment on the skin area monitored during the test
• Subjects with congenital or acquired immunodeficiency
• Subjects under treatment with food supplements which could interfere with the functionality of the product under study
• Subjects which show other skin alterations on the monitored area except for acne lesions
• Subjects with known or suspected sensitization to one or more test formulation ingredients